Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?

Costantini, Adrien; Takam Kamga, Paul; Dumenil, Coraline; Chinet, Thierry; Emile, Jean-François; Giroux Leprieur, Etienne.

Afiliação

Costantini A; Department of Respiratory Diseases and Thoracic Oncology, APHP-Hôpital Ambroise Paré, 92100 Boulogne-Billancourt, France.
Takam Kamga P; EA 4340 BECCOH, UVSQ, Université Paris Saclay, 92100 Boulogne-Billancourt, France.
Dumenil C; EA 4340 BECCOH, UVSQ, Université Paris Saclay, 92100 Boulogne-Billancourt, France.
Chinet T; Department of Respiratory Diseases and Thoracic Oncology, APHP-Hôpital Ambroise Paré, 92100 Boulogne-Billancourt, France.
Emile JF; EA 4340 BECCOH, UVSQ, Université Paris Saclay, 92100 Boulogne-Billancourt, France.
Giroux Leprieur E; Department of Respiratory Diseases and Thoracic Oncology, APHP-Hôpital Ambroise Paré, 92100 Boulogne-Billancourt, France.

Cancers (Basel) ; 11(9)2019 Aug 29.

Article em En | MEDLINE | ID: mdl-31470546